Cassava Sciences Inc financial data

Symbol
SAVA on Nasdaq
Industry
Pharmaceutical Preparations
Location
6801 N Capital Of Texas Highway, Building 1; Suite 300, Austin, TX
State of incorporation
DE
Fiscal year end
December 31
Former names
PAIN THERAPEUTICS INC (to 3/25/2019)
Latest financial report
10-K - Q4 2024 - Mar 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 347 % -66.1%
Debt-to-equity 9.41 % +159%
Return On Assets -12.5 % +76.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48.3M shares +11.8%
Common Stock, Shares, Outstanding 48.2M shares +14.1%
Entity Public Float 558M USD -42.3%
Common Stock, Value, Issued 48K USD +14.3%
Weighted Average Number of Shares Outstanding, Basic 46.3M shares +10.5%
Weighted Average Number of Shares Outstanding, Diluted 46.6M shares +11.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 69.6M USD -22.1%
General and Administrative Expense 71.8M USD +334%
Operating Income (Loss) -141M USD -33.5%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -24.3M USD +75%
Earnings Per Share, Basic -0.53 USD/shares +77.2%
Earnings Per Share, Diluted -1.46 USD/shares +37.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 129M USD +6.14%
Other Assets, Current 38K USD -86.8%
Assets, Current 137M USD +5.32%
Property, Plant and Equipment, Net 21M USD -4.07%
Operating Lease, Right-of-Use Asset 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 37K USD -79%
Assets 158M USD +3.87%
Accounts Payable, Current 10.3M USD +117%
Employee-related Liabilities, Current 1.36M USD +579%
Accrued Liabilities, Current 7.04M USD +112%
Liabilities, Current 11.8M USD -17.2%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 79K USD
Liabilities 11.8M USD -16.7%
Retained Earnings (Accumulated Deficit) -405M USD -6.39%
Stockholders' Equity Attributable to Parent 146M USD +5.99%
Liabilities and Equity 158M USD +3.87%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.1M USD -44.3%
Net Cash Provided by (Used in) Financing Activities 22.2M USD +34525%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 48.2M shares +14.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 189M USD +32.8%
Deferred Tax Assets, Valuation Allowance 96.7M USD +25%
Deferred Tax Assets, Gross 96.7M USD +25%
Depreciation 952K USD -12.2%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Property, Plant and Equipment, Gross 24.2M USD +0.26%
Operating Lease, Liability, Current 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 43.1M USD +29.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 9.24M USD +9.85%
Operating Lease, Payments 0 USD -100%
Additional Paid in Capital 551M USD +6.29%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 180K USD -59.6%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 16.3M USD +255%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%